Novartis’ Intravenou
Novartis’ Intravenous Formulation of Cosentyx Impacting Prescriber Preferences in Psoriatic Arthritis Treatment, While Pending Launch of UCB’s Bimzelx Poised to Further Disrupt the Market
April 16, 2024 14:06 ET | Spherix Global Insights
EXTON, PA, April 16, 2024 (GLOBE NEWSWIRE) -- In October of 2023, the US FDA approved Novartis’ intravenous (IV) formulation of Cosentyx (secukinumab) for the treatment of psoriatic arthritis (PsA),...
Changes Afoot for th
Changes Afoot for the Treatment of Psoriatic Arthritis with Marked Gains in Preference and Utilization of IL-17 Inhibitors
January 22, 2024 10:47 ET | Spherix Global Insights
EXTON, PA, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Since the first US FDA-approved tumor necrosis factor (TNF) inhibitor in 2002 for the treatment of psoriatic arthritis (PsA), TNF’s have upheld their...
Le Ruban Blanc
En tant qu'allié dévoué, le Ruban blanc publie des Vies en Bref qui traitent de la violence à l'encontre des communautés transgenres
November 13, 2023 06:30 ET | Ruban blanc
TORONTO, 13 nov. 2023 (GLOBE NEWSWIRE) -- Le Ruban blanc lance sa toute dernière campagne, Vies en Bref, qui suit la vie d'une femme transgenre depuis sa transition. Cette campagne se penche sur son...
White Ribbon
As a committed ally, White Ribbon releases Short Life Stories addressing violence against the transgender communities
November 13, 2023 06:30 ET | White Ribbon
As a committed ally, White Ribbon releases Short Life Stories addressing violence against the transgender communities.
Consecutive Use of T
Consecutive Use of TNF-Inhibitors for the Treatment of Psoriatic Arthritis at Lowest Point Recorded, as Use of Biologics with Alternate Mechanisms of Actions Continue to Grow, According to Spherix Global Insights
October 03, 2023 13:57 ET | Spherix Global Insights
Exton, Pennsylvania, Oct. 03, 2023 (GLOBE NEWSWIRE) -- US rheumatologists (n=204) report nearly two-thirds of their psoriatic arthritis (PsA) patients are undergoing treatment with advanced systemic...
Medical Courier Market to Hit $10.96 Billion Propelled by Medical Supplies and Equipment Segment During 2020-2030 | The Insight Partners
October 03, 2023 09:36 ET | The Insight Partners
Pune, India, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Medical courier is the supply of samples and equipment related to healthcare and medical requirements can sometimes be urgent and critical. A medical...
Wake Up Narcolepsy Debuts Public Service Announcement in Collaboration with Red Square Pictures
July 11, 2023 11:17 ET | Wake Up Narcolepsy
WORCESTER, Mass., July 11, 2023 (GLOBE NEWSWIRE) -- Wake Up Narcolepsy (WUN), a national leader for research and awareness, premiered its Narcolepsy public service announcement in partnership with Red...
Curium Receives Posi
Curium Receives Positive CHMP Opinion of PYLCLARI® for Primary Staging of Patients With High-Risk PCa Prior to Initial Curative Therapy and to Localize Recurrence of PCa in Patients With a Suspected Recurrence Based on Increasing Serum Prostate-Specific Antigen (PSA) Levels After Primary Treatment With Curative Intent
May 26, 2023 03:42 ET | Curium
If approved for Europe, PYLCLARI® (INN: Piflufolastat (18F) formerly known as [18F]-DCFPyL) will offer prostate cancer patients access to a diagnostic imaging agent more sensitive than conventional...
Prostate Cancer Diagnostics Market to Exceed US$ 8 Billion by 2031 as Adoption of Generic Drugs Gains Momentum Worldwide | Fact.MR Report
April 05, 2023 10:00 ET | FACT.MR
Rockville , April 05, 2023 (GLOBE NEWSWIRE) -- The global prostate cancer diagnostics market is projected to reach US$ 8 billion in 2031. It is anticipated to register growth at a CAGR of 10% from...
CMap: New Research Reveals That Over 80% of Consultancies Are Reluctant to Adopt New Technology
February 14, 2023 09:00 ET | CMap
Manchester, UK, Feb. 14, 2023 (GLOBE NEWSWIRE) -- CMap, the leading provider of industry-tailored project and resource management software, has uncovered the huge potential for consultancies to...